Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Pays » - entrée « Iran »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Indonésie < Iran < Iraq  Facettes :

List of bibliographic references indexed by Iran

Number of relevant bibliographic references: 82.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000091 (2021) Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran]The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
000092 (2021) Mehdi Mesri [Iran] ; Seied Saeid Esmaeili Saber [Iran] ; Mohammadreza Godazi [Iran] ; Aboulfazl Roustaei Shirdel [Iran] ; Reza Montazer [Iran] ; Hamid Reza Koohestani [Iran] ; Nayereh Baghcheghi [Iran] ; Mahmood Karimy [Iran] ; Nemat Azizi [Iran]The effects of combination of Zingiber officinale and Echinacea on alleviation of clinical symptoms and hospitalization rate of suspected COVID-19 outpatients: a randomized controlled trial.
000112 (2021) Batool Zamani [Iran] ; Seyed-Masoud Moeini Taba [Iran] ; Mohammad Shayestehpour [Iran]Systemic lupus erythematosus manifestation following COVID-19: a case report.
000134 (2021) Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran]Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
000159 (2021) Masoud Solaymani-Dodaran [Iran] ; Mostafa Ghanei [Iran] ; Mehdi Bagheri [Iran] ; Ali Qazvini [Iran] ; Ensieh Vahedi [Iran] ; Seyed Hassan Saadat [Iran] ; Seyed Amin Setarehdan [Iran] ; Akram Ansarifar [Iran] ; Hossein Biganeh [Iran] ; Arash Mohazzab [Iran] ; Davood Khalili [Iran] ; Amir Hosein Ghazale [Iran] ; Mohammad Reza Heidari [Iran] ; Ali Taheri [Iran] ; Maliheh Khoramdad [Iran] ; Mohammad Mahdi Asadi [Iran] ; Masoud Nazemieh [Iran] ; Mojtaba Varshochi [Iran] ; Samaneh Abbasian [Iran] ; Ali Bakhtiari [Iran] ; Reza Mosaed [Iran] ; Seyyed-Javad Hosseini-Shokouh [Iran] ; Masoume Shahrokhi [Iran] ; Zeynab Yassin [Iran] ; Mohammad Ali Zohal [Iran] ; Maryam Qaraati [Iran] ; Nafiseh Rastgoo [Iran] ; Ramin Sami [Iran] ; Mohammad Javad Eslami [Iran] ; Akram Asghari [Iran] ; Mansoor Namazi [Iran] ; Shadi Ziaie [Iran] ; Raana Jafari-Moghaddam [Iran] ; Saeid Kalantari [Iran] ; Mohammad Memarian [Iran] ; Javad Khodadadi [Iran] ; Mohammad Hossein Afshari [Iran] ; Mansooreh Momen-Heravi [Iran] ; Niusha Behzadseresht [Iran] ; Ahmad Reza Mobayen [Iran] ; Abolfazl Mozafari [Iran] ; Fatemeh Movasaghi [Iran] ; Maryam Haddadzadeh Shoushtari [Iran] ; Javad Moazen [Iran]Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia.
000160 (2021) Saeidreza Jamalimoghadamsiahkali [Iran] ; Besharat Zarezade [Iran] ; Sogol Koolaji [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Abolfazl Zendehdel [Iran] ; Mohammad Tabarestani [Iran] ; Ehsan Sekhavati Moghadam [Iran] ; Ladan Abbasian [Iran] ; Seyed Ali Dehghan Manshadi [Iran] ; Mohamadreza Salehi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mohsen Meidani [Iran] ; Faeze Salahshour [Iran] ; Fatemeh Jafari [Iran] ; Navid Manafi [Canada] ; Fereshteh Ghiasvand [Iran]Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
000167 (2021) Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran]SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
000168 (2021) Peyman Kheirandish Zarandi [Iran] ; Mohammad Reza Zinatizadeh [Iran] ; Maryam Zinatizadeh [Iran] ; Mohammad Hadi Yousefi [Iran] ; Nima Rezaei [Iran]SARS-CoV-2: From the pathogenesis to potential anti-viral treatments.
000180 (2021) Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran]Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
000250 (2021) Maryam Khoubnasabjafari [Iran] ; Abolghasem Jouyban [Iran] ; Aida Malek Mahdavi [Iran] ; Leila Namvar [Iran] ; Kamal Esalatmanesh [Iran] ; Mehrzad Hajialilo [Iran] ; Saeed Dastgiri [Iran] ; Mohsen Soroush [Iran] ; Saeid Safiri [Iran] ; Alireza Khabbazi [Oman]Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: a multicentre cross-sectional study.
000253 (2021) Leila Simani [Iran] ; Mahtab Ramezani [Iran] ; Ilad Alavi Darazam [Iran] ; Mastooreh Sagharichi [Iran] ; Mohammad Amin Aalipour [Iran] ; Fatemeh Ghorbani [Iran] ; Hossein Pakdaman [Iran]Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
000255 (2021) Zahra Teimouri-Jervekani [Iran] ; Mehrzad Salmasi [Iran]Presentation of COVID-19 infection with bizarre behavior and encephalopathy: a case report.
000293 (2021) Maziar Emamikhah [Iran] ; Mansoureh Babadi [Iran] ; Mehrnoush Mehrabani [Iran] ; Mehdi Jalili [Iran] ; Maryam Pouranian [Iran] ; Peyman Daraie [Iran] ; Fahimeh Mohaghegh [Iran] ; Sharmin Aghavali [Iran] ; Maryam Zaribafian [Iran] ; Mohammad Rohani [Iran]Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
000308 (2021) Javad Mahmoudi [Iran] ; Saeed Sadigh-Eteghad [Iran] ; Hanieh Salehi-Pourmehr [Iran] ; Afshin Gharekhani [Iran] ; Mojtaba Ziaee [Iran]Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients.
000358 (2021) Hassan Askari [Iran] ; Nima Sanadgol [Iran, Brésil] ; Asaad Azarnezhad [Iran] ; Amir Tajbakhsh [Iran] ; Hossein Rafiei [Canada] ; Ali Reza Safarpour [Iran] ; Seyed Mohammad Gheibihayat [Iran] ; Ehsan Raeis-Abdollahi [Iran] ; Amir Savardashtaki [Iran] ; Ali Ghanbariasad [Iran] ; Navid Omidifar [Iran]Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
000377 (2021) Mohsen Farrokhpour [Iran] ; Nader Rezaie [Iran] ; Najmeh Moradi [Iran] ; Fatemeh Ghaffari Rad [Iran] ; Shirin Izadi [Iran] ; Mehdi Azimi [Iran] ; Farhad Zamani [Iran] ; Shahrokh Izadi [Iran] ; Mitra Ranjbar [Iran] ; Mahin Jamshidi Makiani [Iran] ; Azadeh Laali [Iran] ; Maryam Roham [Iran] ; Mahdi Yadollahzadeh [Iran]Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.
000481 (2021) Razieh Morad [Afrique du Sud] ; Mahmood Akbari [Afrique du Sud] ; Parham Rezaee [Iran] ; Amin Koochaki [Iran] ; Malik Maaza [Afrique du Sud] ; Zahra Jamshidi [Iran]First principle simulation of coated hydroxychloroquine on Ag, Au and Pt nanoparticles.
000508 (2021) Payam Tabarsi [Iran] ; Saghar Barati [Iran] ; Hamidreza Jamaati [Iran] ; Sara Haseli [Iran] ; Majid Marjani [Iran] ; Afshin Moniri [Iran] ; Zahra Abtahian [Iran] ; Alireza Dastan [États-Unis] ; Sahar Yousefian [Iran] ; Raha Eskandari [Iran] ; Ali Saffaei [Iran] ; Fatemeh Monjazebi [Iran] ; Abdolbaset Vahedi [Iran] ; Farzaneh Dastan [Iran]Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial.
000524 (2021) Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran]Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.
000539 (2021) H. Rahimi [Iran] ; A. Allahyari [Iran] ; S. Ataei Azimi [Iran] ; M. Kamandi [Iran] ; Z. Mozaheb [Iran] ; F. Zemorshidi [Iran] ; M. Khadem-Rezaiyan [Iran] ; A. Bary [Iran] ; M. Seddigh-Shamsi [Iran] ; M Moeini Nodeh [Iran]Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial.
000543 (2021) Seyed Parsa Eftekhar [Iran] ; Sohrab Kazemi [Iran] ; Mohammad Barary [Iran] ; Mostafa Javanian [Iran] ; Soheil Ebrahimpour [Iran] ; Naghmeh Ziaei [Iran]Effect of Hydroxychloroquine and Azithromycin on QT Interval Prolongation and Other Cardiac Arrhythmias in COVID-19 Confirmed Patients.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i -k "Iran" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i  \
                -Sk "Iran" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Iran
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021